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Background: This study interviewed community pharmacists in Shanghai and Guangzhou for their perception of
the popular categories of over-the-counter (OTC) Chinese medicines and the factors affecting customer preferences
for OTC Chinese medicines.
Methods: A cross-sectional survey was carried out in six main administrative districts in Guangzhou and eight main
administrative districts in Shanghai, China. Descriptive statistical analysis was conducted in this study.
Results: OTC Chinese medicines contributed 21–50% among all the pharmaceutical sales by the community
pharmacies. The prevalent categories of OTC Chinese medicines were common cold medicines, respiratory system
medicines, digestive system agents, gynecological medicines, health tonic medicines, and qing re (heat-clearing) and
qu du (detoxifying) medicines. Customers were more concerned about medical factors of OTC Chinese medicines
than business factors. Among the medical factors, the most important was drug safety, followed by efficacy,
contraindications, indications, and side effects. Among the business factors, the most important were brand
and price.
Conclusions: This study identified the top sales categories of OTC Chinese medicines in Shanghai and Guangzhou
and the important factors such as drug safety, efficacy, period of validity, contraindications, and indications that are
affecting the customer preferences for OTC Chinese medicines.Background
Self-medication is becoming an increasingly important
part of global healthcare systems where aging popula-
tions experience a higher prevalence of chronic medical
conditions [1,2], including China where the pace of
aging has been accelerating in the past decade [3]. Con-
venient self-medication with fewer adverse drug reac-
tions is preferred [4]. Consequently, over-the-counter
(OTC) medicines are gaining a significant presence in
the pharmaceutical sector. For example, US sales of
OTC Chinese medicines were about 1.7 billion US dol-
lar in 2010 and there are approximately 100 000 OTC
products available in the US market [5,6]. These* Correspondence: haohu@umac.mo
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unless otherwise stated.demographic and socioeconomic changes present op-
portunities for Chinese medicines in the OTC market.
Chinese medicines confer advantages in the self-
medication OTC market and increase drug accessibility
for patients [7]. Specifically, OTC Chinese medicines are
usually used without professional supervision [8], and
their target mild diseases and chronic medical conditions
do not need regular dose adjustments for long periods of
time [9-11]. In addition, OTC Chinese medicines are more
widely accepted than conventional Western medicines
(WM) because of Chinese patients’ beliefs and preferences
for natural products and alternative medicines [12-14].
The factors that affect customer preferences for OTC
Chinese medicines are under study to promote research
and development (R&D) of OTC Chinese medicines. As
an important part of research on traditional ChineseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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contribute to the proposal of priority areas for future re-
search and new drug innovations. Yu [15] proposed that
medicinal products’ quality and brand are the most crit-
ical factors for OTC Chinese medicine acceptance by
customers. Toxic contaminants in OTC Chinese medi-
cines are frequently discussed as a safety issue [16,17].
The appropriate dosages and schedules required to
avoid common adverse reactions have also been the
subject of research [18,19]. Moreover, researchers have
begun to pay more attention to the cognitive prefer-
ences for OTC Chinese medicines [20]. Hon et al. [21]
tested pharmacy students’ attitudes toward OTC
Chinese medicines, and discovered that pharmacy stu-
dents’ cognitive understanding of Chinese medicines
significantly affected their attitudes toward OTC Chin-
ese medicines. Chung et al. [22] investigated the use of
OTC and prescription medicines across WM and TCM
among urban Chinese patients and found that sugges-
tions from healthcare professionals were highly relevant
to patients’ preferences for use of OTC products, re-
gardless of whether WM or TCM was involved. How-
ever, related empirical studies remained limited and did
not provide adequate knowledge of customer prefer-
ences for the development of OTC Chinese medicines.
Hospitals and community pharmacies were two main
distribution channels for OTC Chinese medicines in
China. Chinese medicines were widely used for treating
cardiovascular and cerebrovascular diseases in hospitals
(Additional file 1). This was followed by their use for
cancer, and Chinese medicines were reported to cause
less suffering and have significant efficacy in cancer
treatment [23]. Chinese medicines were also widely
used to treat respiratory diseases, musculoskeletal dis-
eases, gynecological diseases, and urinary system dis-
eases in hospitals. However, the most prevalent Chinese
medicines used in hospitals were mostly Chinese medi-
cine injections and belonged to the prescription medi-
cations [24]. OTC Chinese medicines did not have a
significant presence in hospitals compared with pre-
scription Chinese medicines [25,26].
Consequently, the most important market for OTC
Chinese medicines in China is the community phar-
macy [27,28]. However, no previous publications have
focused on the popularity of OTC Chinese medicines in
community pharmacies. The popular categories of OTC
Chinese medicines in the community pharmacy market
remained undefined and the factors affecting customer
preferences for OTC Chinese medicines in community
pharmacies were unknown.
This study aims to survey the popular categories of
OTC Chinese medicines in community pharmacies in
China and the factors affecting customer preferences for
OTC Chinese medicines.Methods
Data collection
This study used a paper-form questionnaire to collect
first-hand data about OTC Chinese medicines in com-
munity pharmacies. The survey design was reviewed and
approved by the Ethics Committee of the Research
Committee at the University of Macau. Shanghai and
Guangzhou were chosen as the target cities for this
study because of their economic backgrounds, huge
populations of TCM users, and citizens’ acceptance to-
ward TCM products as OTC Chinese medicines [29]. In
more detail, the sales within the TCM industry in Guang-
dong province were 8.9 billion RBM, and accounted for
9.1% of the whole country sales in 2005. The proportion
of facilities with a TCM department among all 228 com-
munity health centers in Shanghai was 93.4% in 2006. The
two cities also have centralized leading TCM science and
research institutes, including over 30 TCM research la-
boratories in Shanghai and 21 research institutes in
Guangzhou [30-32]. The TCM culture in the two cities
is also time-honored, for instance, there are more than
four old-brand TCM enterprises established before the
19th century, indicating a long history of TCM use in
Guangzhou [33].
Therefore, the information collected from community
pharmacies in both cities could provide informative re-
sults about the popularity and customer preferences for
OTC Chinese medicines in China.
The naive theory of popularity explained the belief that
a product is desirable when it is popular [34,35]. The
concept “popularity” was defined as a mixture of best-
selling and prevalence, with the aim of indicating the
market potential of OTC products. Because there was
no reliable statistical information about the total num-
ber of community pharmacies in both cities, stratified
sampling from different city districts was conducted to
ensure that the study could collect information from
community pharmacies located in different social and
economic environments. All of the main administrative
districts in Guangzhou were chosen, namely Tianhe,
Yuexiu, Baiyun, Liwan, Huangpu, and Dongshan. The sur-
vey also covered all of the main administrative districts in
Shanghai, including Huangpu, Luwan, Xuhui, Jingan,
Putuo, Yangpu, Minhang, and Jinshan. The whole survey
was conducted and completed in May 2013.
The pharmacist in charge of pharmaceutical services at
each community pharmacy was targeted as the survey re-
spondent. During visits to the community pharmacies,
one researcher involved in the study as an investigator ob-
tained informed consent in oral form from the respon-
dents before the formal survey, following a standardized
process: (1) introducing the researcher herself at first; (2)
explaining research background and research objective in
a structural way, with the cover page of questionnaire
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anonymous nature of this survey; and (4) consulting the
agreement of respondents. If there were any doubts in the
survey, the investigator would spell out more specific in-
formation for the respondents in a word-by-word manner.
The questionnaires were completed by the community
pharmacists themselves without any intervention. All of
the questionnaires were distributed directly to the respon-
dents and collected on site in the same visit.
Measurements
A semi-structured questionnaire (Additional file 2) was
used in this study. The questionnaire was composed of
three parts. The first part solicited background informa-
tion about the community pharmacy, specifically the year
of establishment, number of employees, business area,
geographic position, form of ownership, management
model (chain drugstore or not), involvement in social
medical security (yes or no), average number of daily cus-
tomers, and provision of medical care services (yes or no).
The second part of the questionnaire solicited infor-
mation about the popularity of OTC Chinese medicines.
The respondents were asked to choose the sales propor-
tions of four items: pharmaceutical sales/gross turnover;
prescription medicine sales/pharmaceutical sales; OTC
medicine sales/pharmaceutical sales; and OTC Chinese
medicine sales/pharmaceutical sales. In addition, the re-
spondents were asked to write down the five most popu-
lar categories of OTC Chinese medicines and the three
best-selling products in each category.
The third part of the questionnaire investigated the
factors affecting customer preferences for OTC Chinese
medicines. The possible factors were divided into med-
ical factors and business factors. The medical factors of
OTC Chinese medicines referred to medicine safety, effi-
cacy, dosage form, indications, contraindications, period
of validity, and side effects. The business factors of OTC
Chinese medicines referred to price, brand, production
area, packaging, and label design, and whether the medi-
cine was listed in the Catalogue of Drugs for Basic
National Medical Insurance and Countermeasures of
China (the Catalogue) [36]. The respondents were asked
about the extent to which, in their experience, each fac-
tor influenced customer preferences for OTC Chinese
medicines, measured on a 5-point Likert scale (1 = not
at all; 5 = very great). After the choices made by each re-
spondent, the degree of influence was defined as the total
choices related to each level (not at all, very great, or others)
divided by the total number of respondents in percentages.
Data analysis
Preliminary analyses of the data collected in this study
showed that there were no significant differences among
the cities, geographic positions, forms of ownership, andbusiness areas of the community pharmacies. Overall,
the study aimed to provide a comprehensive exploration
of OTC Chinese medicines in the community pharmacy
market, rather than specific tests of community phar-
macy factors. Therefore, the survey questionnaire data
were analyzed through descriptive statistics. All the data
for the background information of the community pharma-
cies, sales proportion items, and factors affecting customer
preferences were analyzed through percentage distribu-
tions. The data for the popular categories of OTC Chinese
medicines were analyzed by ordination methods through
counting frequencies. The data for the popular products in
each category were presented in word descriptions.Results
Background information for the community pharmacies
evaluated
A total of 108 community pharmacies in Guangzhou were
visited, and 51 respondents completed the questionnaire.
In Shanghai, 137 community pharmacies were visited, and
52 respondents completed the questionnaire. In total, 103
completed questionnaires were collected, with a response
rate of 42%, reflecting the difficulties in acquiring the co-
operation of community pharmacists [37]. After deleting
questionnaires with missing answers, 100 valid question-
naires were finalized for further analyses.
The year of establishment for the community pharma-
cies evaluated ranged from 1992 to 2012. On average,
the community pharmacies had operated for 8 years.
The number of employees ranged from 2 to 63, with an
average of 9.82 per community pharmacy.
As shown in Table 1, 42% of the community pharma-
cies had a business area of 50–100 m2 and 38% of the
community pharmacies had a business area of 100–
150 m2. The majorities (78%) of the community pharma-
cies evaluated were located in a residential community,
20% were in a business community, and the final 2%
were in remote areas. The majority (86%) of the commu-
nity pharmacies were privately owned, 6% were state-
owned, 4% belonged to foreign investors, and 4% were
joint ventures between two ownership groups.
Sixty-four per cent of the community pharmacies were
chain drugstores and 36% were single drugstores. Fifty-
two per cent of the community pharmacies were involved
in China’s social medical security system. Through this
system, Chinese citizens can defray some of the costs of
medical expenses in the event of illness or injury, includ-
ing expenditure on OTC Chinese medicines. However,
only 20% of the community pharmacies offered medical
care services. Thirty per cent of the community pharma-
cies served an average of 51–100 drug-purchasing cus-
tomers daily and 18% of the community pharmacies
served over 250 drug-purchasing customers each day.
Table 1 Background information of the studied
community pharmacies (N = 100)
Background Percentage
Geographic position Residential community 78%
Business community 20%
Remote areas 2%










Offer medical care services Yes 20%
No 80%














Table 2 Categories of OTC Chinese medicine in the
community pharmacies
Category no. Categories Frequency Percentage
1 Cold medicine 91 18%
2 Respiratory system medicine 72 14%
3 Digestive system agent 67 13%
4 Gynaecological medicine 63 13%




7 ENT medicine 28 6%
8 Dermatology medicine 24 5%
9 Circulatory system agent 17 3%
10 Orthopaedics medicine 15 3%
11 Summer humidity agent 8 2%
12 Nervous system medicine 1 0%
Total — 500 100%
*Heat-clearing and detoxifying means Qingre Jiedu.
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medicines and Chinese medicines. OTC medicines con-
tributed more toward sales income than prescription
medicines. OTC Chinese medicines contributed 21–50%
of the income from pharmaceutical sales for the majority
of the community pharmacies (Additional file 3).
Popular categories of OTC Chinese medicines in the
community pharmacies
The six most popular categories of OTC Chinese medi-
cines were cold medicines, respiratory system medicines,
digestive system agents, gynecological medicines, health
tonic medicines, and heat-clearing and detoxifying medi-
cines (Table 2). The total frequency of these six categor-
ies in the data was approximately 81%.
According to respondents’ answers about the sales situ-
ation for OTC Chinese medicine products, the most popu-
lar products in each of the six most prevalent categories of
OTC Chinese medicines were summarized in ordination
(Table 3). These items comprised common products in
OTC markets. For example, Xiaochaihu granules, madewith the traditional Chinese medicines Bupleurum chinense
and Scutellaria baicalensis, have obvious curative powers
for flu and gastrointestinal dysfunction [38].
Factors affecting customer preferences for OTC
Chinese medicines
The medical factors were the key factors affecting cus-
tomer preferences for OTC Chinese medicines. Of the
medical factors, medicine safety was the most important.
The next most important factors were efficacy and
period of validity. The factors of contraindications, indi-
cations, and side effects also had strong effects on cus-
tomer decision-making. The dosage form did not have a
strong effect on customer preferences (Figure 1).
The business factors, namely price, production area,
brand, inclusion in the Catalogue, packaging, and label de-
sign, did not have such clear effects on customer prefer-
ences for OTC Chinese medicines. The medicine brand
was a relatively more important factor, as were price and
production area. Patients rarely considered packaging and
label design, and did not consider whether their OTC
Chinese medicine purchases were listed in the Catalogue,
implying that their decision-making was not influenced by
whether they would be reimbursed for their OTC Chinese
medicines (Figure 2). As mentioned before, China’s social
medical insurance system was established to provide med-
ical reimbursement and basic medical services to citizens,
and the Catalogue is an important part of the system [39].
The Catalogue is able to balance the prices in the OTC
market to some degree by adjusting the OTC medicines
listed in the Catalogue [40]. However, similar to the con-
sumer awareness of drug prices, the attention paid to the
Catalogue was relatively low.
Table 3 Popular products within the six most
popular categories
Categories Popular products
Cold medicine 999 Ganmaoling granule
Xiaochaihu granule
Vitamin C Yinqiao tablet
Antiviral oral-liquid
Lianhua Qingwen capsule
Respiratory system medicine Milian Chuanbei Pipa paste















Health tonic medicine Donkey-hide gelatin
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Based on the survey data, OTC Chinese medicines
accounted for a high proportion of pharmaceutical sales
in the community pharmacies evaluated, suggesting that
OTC Chinese medicines have wide acceptance by Chinese
customers and great potential in the self-medication mar-
ket in China, especially through the distribution channel
of community pharmacies.
The most common uses of Chinese medicines in hos-
pitals are for the treatment of cardiovascular diseases,
cancer, and other serious illnesses (see Additional file 1),
which are obviously different from the uses of OTC
Chinese medicine at community pharmacy. Thus, OTCChinese medicine producers could make use of their com-
parative advantages for common diseases and health
maintenance areas, which have been regarded as one of
the main strengths of Chinese medicines [41]. Thus, fu-
ture R&D by OTC Chinese medicine producers could
focus on the common disease areas targeted by Chinese
medicines. For instance, Valerian extract capsules for the
treatment of digestive system diseases and Jinggan cap-
sules for the treatment of common colds were developed
in 2011, and both focus on common disease areas [42].
Future R&D could also focus on the further development
of existing OTC Chinese medicines and the improvement
of their dose calculations to enlarge their market existence
and increase customer acceptance.
According to the perceptions of community pharma-
cists, medicine safety and other medical factors were
the key factors affecting customer preferences for OTC
Chinese medicines. The community pharmacists surveyed
thought that their customers were influenced more by
medical factors than by business factors. Therefore, med-
ical factors, comprising medicine safety, efficacy, period of
validity, contraindications, indications, and side effects,
were more influential factors for customers when choos-
ing OTC Chinese medicines. Although most Chinese
medicines are developed from natural products, safety
problems have frequently been reported [43,44]. Over the
past decade, a number of OTC Chinese medicines have
been featured in the news after patients developed serious
adverse effects arising from problems with the products,
such as high heavy metal levels found in an aloe com-
pound capsule and acute kidney injury caused by Han fang
ji (Stephania tetrandra) [45]. Another medicine safety
issue is improper use in self-medicating because of lack of
knowledge [46-48]. Some OTC Chinese medicines might
be subject to inadequate quality control and contain
harmful additives or unlisted ingredients [49,50]. Further-
more, interactions between different products used simul-
taneously might cause serious problems [51,52].
Therefore, medicine safety should be the most import-
ant factor under consideration in drug use, especially the
pharmacological, pharmacodynamics, and toxicological
aspects, and adverse reactions of OTC Chinese medi-
cines [53], as also identified in this study. In particular,
rigorous guidelines and clinical trials specific to OTC
Chinese medicines were required to be advanced and
applied to ensure that clinical research is honest and re-
liable [54]. In addition, unsafe OTC Chinese medicines
might arise from unprofessional practices by manufac-
turers [55]. Some of these problems could be controlled
by the development of standard operating procedures
for the industry, including good agricultural practice,
good supply practice, and good manufacturing practice
for implementation during OTC Chinese medicine
production [56].
Figure 1 Medical factors affecting customer preference for OTC Chinese medicine.
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preferences for OTC Chinese medicines, such as dosage
form, packaging, and label design. Reimbursement and
price were also not important. This might be because the
medical security system in China was improved after the
New Healthcare Reform, which included the addition ofFigure 2 Business factors affecting customer preference for OTC Chinmany more OTC Chinese medicines to the Catalogue
[57]. Overall, 203 Chinese medicines were listed in the na-
tional essential drugs lists in 2012, occupying approxi-
mately one-third of the whole Catalogue [58]. Moreover,
OTC Chinese medicines always have a competitive price
advantage over most conventional WM [59,60]. Thus,ese medicine.
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growth in therapeutic areas, and it will be rewarding
for producers to invest more money into R&D for OTC
Chinese medicines.
Several study limitations should be addressed in fu-
ture studies. First, the survey used for data collection
was restricted to specific areas. Although Shanghai and
Guangzhou could provide information about the main
consumption of OTC Chinese medicines in China, the
results may not accurately represent the situations in
middle- and small-sized cities. Future studies covering
more geographical areas would provide more complete
information about OTC Chinese medicines in different
economic and social contexts. Second, this study was
based on the perceptions of community pharmacists ra-
ther than direct measurements of OTC Chinese medi-
cine consumption. Future studies could be advanced
through the creation of new methods to collect direct
consumption data. Third, this study used an overview of
the popular categories and products of OTC Chinese
medicines. Further research could focus on specific cat-
egories. The treatment areas of cold medicines and di-
gestive system agents, for example, contain various
complex OTC Chinese medicines and require more de-
tailed study.
Conclusions
This study identified the top sales categories of OTC
Chinese medicines in Shanghai and Guangzhou and the
important factors such as drug safety, efficacy, period of
validity, contraindications, and indications that are affect-
ing the customer preferences for OTC Chinese medicines.Additional files
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